Hyppää sisältöön

MEDICAL FACILITIES CORP

MEDICAL FACILITIES CORP on Kanadalainen sairaalapalveluja ja tiloja Yhdysvalloissa tarjoava yritys. Filosofialtaan DR on hieman erillainen palvelujen tuottaja. Yritys tarjoaa lääketieteen ammattilaisille tilat toimia; lääkärit, fysioterapeutit, hoitajat ovat yrityksen 'kumpaneita'. Eli MEDICAL FACILITIES CORP johtamia sairaaloita tai terveyskeskuksia ei johdeta perinteisen mallin mukaan.

Tarkemmin voi yritykseen tutustua sen sivuilta:

https://www.medicalfacilitiescorp.ca/

Taloustietoja

Net Income -4000-4000-2000-200000200020004000400060006000800080001000010000120001200014000140001600016000180001800020000200002200022000Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q12017-323041.32692307692307437.97029534846513Q22019-5283100.36538461538461456.4811825165384Q1201919963159.40384615384616228.85046773564306Q420188007218.4423076923077336.6518155103553Q3201813050277.4807692307693291.18157489243345Q2201810529336.5192307692308313.9121869483091Q1201817551395.5576923076923250.59828061893228Q420172165454.5961538461538389.326244558521Q3201722124513.6346153846155209.36579790115385Q220174739572.6730769230768366.1177576756079Q12017Net IncomeNet Income Total Revenue 00100001000020000200003000030000400004000050000500006000060000700007000080000800009000090000100000100000110000110000120000120000Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q1201710098839.22692307692307301.6893529521508Q220199909595.26538461538462305.48378870628494Q12019123283151.3038461538461257.0Q42018104207207.34230769230766295.237008159463Q32018106494263.3807692307692290.6528166276591Q2201897618319.41923076923075308.4443706444023Q12018111266375.45769230769224281.08755121892784Q4201788974431.4961538461538325.77089080221305Q3201796085487.5346153846154311.51720213467576Q2201789004543.5730769230768325.710757113558Q12017Total RevenueTotal Revenue Total Asset 00100000100000200000200000300000300000400000400000500000500000Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q1201749725940.357692307692304273.4239147340501Q2201953266198.01153846153846257.0Q12019481787155.66538461538462280.60178063894875Q42018469644213.31923076923078286.2352362803128Q32018473614270.9730769230769284.3934493334121Q22018477357328.6269230769231282.65697363007473Q12018459588386.28076923076924290.90047797755045Q42017460407443.93461538461537290.5205224335929Q32017467856501.5884615384616287.0647362956928Q22017470806559.2423076923077285.6961540555524Q12017Total AssetTotal Asset Total liabilities 0040000400008000080000120000120000160000160000200000200000240000240000280000280000320000320000Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q1201733233738.09615384615385273.5019767648321Q2201935611892.51923076923077257.0Q12019286149146.94230769230768305.55249200027475Q42018283247201.3653846153846307.56623139607575Q32018278080255.78846153846155311.1516867572417Q22018279007310.2115384615385310.5084281700923Q12018259060364.6346153846154324.3499373803065Q42017263115419.0576923076923321.5361147579864Q32017257449473.48076923076934325.46783337156614Q22017267509527.9038461538462318.48705517661176Q12017Total liabilitiesTotal liabilit…Total liabilities Equity 002000020000400004000060000600008000080000100000100000120000120000140000140000160000160000180000180000200000200000Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q1201716492243.184615384615384310.4204815867855Q22019176543104.87692307692308296.7720388799583Q12019195638166.56923076923078274.3456544477352Q42018186397228.26153846153846285.19887353850106Q32018195534289.95384615384614274.4677986729748Q22018198350351.6461538461538271.1605088818703Q12018200528413.3384615384615268.602526934063Q42017197292475.0307692307692272.403091480943Q32017210407536.723076923077257.0Q22017203297598.4153846153846265.35043693705717Q12017EquityEquity ROE(E/I) -50-50-40-40-30-30-20-20-10-1000101020203030404050506060707080809090Q22019Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q12017-51.0643.09930069930069415.37699556930863Q22019-33.42102.95944055944054384.72001980015904Q220199.8162.81958041958043309.60695331814964Q1201923.28222.67972027972027286.17974054217814Q4201814.98282.53986013986014300.60450805260564Q3201818.84342.4293.8961221983586Q2201811.43402.26013986013976306.7741375299572Q1201891.13462.1202797202797168.2616109539241Q420179.51521.9804195804196310.1109512191164Q3201742.9581.8405594405594252.08167565608315Q22017ROE(E/I)ROE ROE(I/E)% -2-2-1-1001122334455667788991010Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q12017-1.9645.93076923076923430.52991452991455Q22019-2.99111.54615384615386449.3839031339031Q1201910.2177.16153846153844207.94301994301995Q420184.3242.77692307692305315.94159544159544Q320186.67308.39230769230767272.5591168091168Q220185.31374.00769230769225297.4537037037037Q120188.75439.62307692307684234.4850427350427Q420171.1505.2384615384615374.517094017094Q3201710.51570.8538461538462202.2685185185185Q220172.33636.4692307692308352.0021367521367Q12017ROE(I/E)%ROE% Dept/equity% 002020404060608080100100120120140140160160180180200200Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q12017201.5141.56923076923077257.25725872877865Q22019201.72100.95384615384616257.0Q12019146.26160.33846153846156324.9408052288778Q42018151.96219.72307692307692317.95806830488567Q32018142.22279.10769230769233329.88997315395295Q22018140.66338.4923076923077331.80103799630865Q12018129.19397.8769230769231345.85226475388583Q42017133.36457.26153846153846340.74384142528106Q32017122.36516.6461538461539354.21929864702025Q22017131.59576.0307692307691342.9121649964154Q12017Dept/equity%Dept/equity RNV/Equity% 00101020203030404050506060Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q1201761.2341.973076923076924264.0189866464859Q2201956.13101.9346153846154284.01721675658524Q1201963.02161.89615384615388257.0Q4201855.91221.85769230769233284.8798855064327Q3201854.46281.8192307692308290.56565681224527Q2201849.22341.78076923076924311.11285794497473Q1201844.38401.7423076923077330.09157044161805Q4201748.7461.70384615384614313.15189317188685Q3201742.29521.6653846153846338.2869235651686Q2201754.73581.6269230769229289.5069269828871Q12017RNV/Equity%RNV/Equity% Equity ration 001010202030304040Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q1201733.1740.842307692307685321.8423735481774Q2201933.1499.18846153846154322.00722704024906Q1201940.61157.53461538461536280.95870751441134Q4201839.69215.88076923076923286.01421460460824Q3201841.29274.2269230769231277.2220283607876Q2201841.55332.5730769230769275.7932980961667Q1201843.63390.9192307692307264.3634559791998Q4201742.85449.26538461538456268.6496467730624Q3201744.97507.61153846153843257.0Q2201743.18565.9576923076922266.83625836027437Q12017Equity rationEquity ration Current Ration 000.20.20.40.40.60.60.80.8111.21.21.41.41.61.61.81.8222.22.22.42.4Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q120171.1439.87307692307692386.73557692307696Q220191.1496.83461538461539386.73557692307696Q120191.33153.79615384615386367.17227564102564Q420181.75210.75769230769228323.92708333333337Q320180.93267.7192307692308408.3581730769231Q220180.94324.6807692307692407.32852564102564Q120181.31381.64230769230767369.23157051282055Q420172.4438.6038461538461257.0Q320172.26495.56538461538463271.41506410256414Q220172.36552.5269230769231261.1185897435897Q12017Current RationCurrent Ration Working Capital TurnOver -12-12-10-10-8-8-6-6-4-4-2-200224466Q22019Q12019Q42018Q32018Q22018Q12018Q42017Q32017Q22017Q120176.8739.3076923076923198.49018387666615Q220196.2495.46153846153847106.61558535410313Q120193.71151.61538461538458139.246165890477Q420182.02207.76923076923075161.0428777902682Q32018-11.7263.92307692307696337.9960655211177Q22018-12.29320.0769230769231345.60556849205074Q120182.63376.2307692307692153.1754255660832Q420171.27432.38461538461536170.71597478721696Q320171.22488.5384615384616171.36084792034688Q220171.57544.6923076923076166.84673598843747Q12017Working Capital TurnOverWorking Capita…Working Capital TurnOver

Historalliseia kommenteja.

13.8.2019

Kahden peräkkäisen kvartaalin negatiivinen tulos aiheutti varsinaisen syöksylaskun yhtiön osakkeen arvoon, jonka seurauksena yhtiön dividend yield nousi tuntuvasti. Yhtiötä olisi todella houkuttelevaa ostaa, mutta vaikka luulen ettei osinkotuottoa tulla juuri muuttamaan tulevaisuudessa, niin katson kuitenkin kolmannen kvartaalin tuloksen ennen kuin lisään tällä yhtiöllä painoa salkussani.